Akros SCHK HK-Global Genomics Index

Natera is expected to report its Q1 2026 earnings on May 7, 2026, with analysts forecasting an EPS of approximately -$0.55. Market impact is estimated at ≥1% as earnings dates are routine; scheduled.

Tempus AI is expected to announce its Q1 2026 earnings results on 2026-05-05. This routine announcement is estimated to have a ~1% price impact based on historical trends expected.

Announced a strategic collaboration with Daiichi Sankyo on 2026-03-25 to use Tempus' AI models to accelerate the clinical development of an antibody drug conjugate (ADC) program in oncology.